Loading clinical trials...
Loading clinical trials...
IRAPID: Infliximab Infusion Rate in Pediatric Inflammatory Bowel Disease. a Randomized Non-inferiority Trial of Infusion Reactions with Infliximab Infusion-rates of 30 Minutes and 60 Minutes
Conditions
Interventions
Infusion rate of infliximab
Locations
1
Norway
Akershus University Hospital
Lørenskog, Norway
Start Date
February 1, 2025
Primary Completion Date
April 1, 2026
Completion Date
April 1, 2026
Last Updated
February 27, 2025
NCT07385807
NCT07089420
NCT07373457
NCT07353853
NCT07284836
NCT07239687
Lead Sponsor
University Hospital, Akershus
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions